Review Article
Lung Cancer: A Classic Example of Tumor Escape and Progression While Providing Opportunities for Immunological Intervention
Table 2
Types of immunotherapy for lung cancer.
| (1) Active vaccination: subunit vaccines from tumor lysates | | (2) Passive antibody administration | | (a) Direct tumor binding: various tumor antigens | | (b) Indirect approaches: anti-VEGF, anti-CTLA-4 anti-PD-1/PD-L1, and anti-Treg | | (3) Passive cell-mediated administration | | (a) LAK cells | | (b) TIL/draining lymph nodes T cells | | (c) γδ T cells | | (4) Gene therapy | | (a) IL-4 | | (b) GM-CSF | | (c) MHC and/or costimulator molecules | | (d) TGF-β knockdown | | (5) Dendritic cell vaccination | | (a) Peptides | | (b) Tumor lysates | |
|
|